Guangzhou Baiy | 600332 - Interest Expense On Debt


Guangzhou Baiy reported CNY102.39M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.





Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 301.5M Jun/2024
Cipla INR 167.4M 2.9M Sep/2026
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Kalbe Farma IDR 9.69B 689.63M Sep/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sh Fosun Pharma CNY 321.25M 2M Sep/2025
Sh Pharmaceutical CNY 63.66M 379.95M Sep/2025
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
Teva Pharmaceutical Industries USD 195M 21M Jun/2026